Insights On CONTRACT PHARMA MANUFACTURING

  1. ElevateBio BaseCamp Cleanroom Expansion 7/30/2026

    Expanding active cleanrooms risks environmental stability. A risk-based commissioning strategy protects ongoing production, verifies HVAC performance, and streamlines qualification timelines.

  2. Why US Pharma Manufacturing Delivers Strategic Value 7/28/2026

    Domestic pharmaceutical manufacturing strengthens supply chain resilience, simplifies distribution, speeds market response, and reduces risk by aligning production with key markets.

  3. From Cell Bank To Clinic Faster: GMP Manufacturing & Characterization 7/28/2026

    Accelerate your path to the clinic with an integrated, risk-based cell banking strategy that delivers speed, quality, and regulatory confidence at every stage.

  4. Target Product Profile (TPP) Explained 7/27/2026

    Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.

  5. Drug Development Readiness: Interactive Checklist And RACI 7/27/2026

    Early decisions can have long-lasting consequences for development timelines, cost, risk, and overall probability of success. Engaging the appropriate disciplines early helps avoid downstream surprises and rework.

  6. Fewer Setbacks, Faster To IND 7/25/2026

    Cy Credille, Group Leader in process chemistry at Cambrex Longmont, on the setbacks that come as standard in early development — and why a team that has seen them all before is the fastest route to the IND finish line.

  7. Ask Us Anything: Cy Credille 7/24/2026

    Learn how we balance discovery and development as an asset scales, and how the One Cambrex model keeps the original process scientists attached to a molecule from first kilos through NDA.

  8. 5 Must-Haves From Your Peptide Building Block Supplier 7/24/2026

    Whether you are just entering the peptide market or scaling an established product, access to a reliable supply of high-quality building blocks is critical to running a successful peptide program.

  9. Ask Us Anything: Eric Fang On Lithiation Chemistry 7/24/2026

    Eric Fang, General Manager of Snapdragon Chemistry, on why lithiation chemistry resists batch scale-up — and how a decade spent understanding static mixing lets Snapdragon carry these reactions from milligrams to metric tons.

  10. Solutions For Overcoming New Challenges In Pharmaceutical Development 7/24/2026

    Eric Fang on meeting new pharmaceutical development challenges with a two-part investment — technology that answers R&D questions faster, and scientists given the support to tackle what technology can't.